Bayesian cost-effectiveness analysis from clinical trial data

被引:71
|
作者
O'Hagan, A [1 ]
Stevens, JW
Montmartin, J
机构
[1] Univ Sheffield, Dept Probabil & Stat, Sheffield S3 7RH, S Yorkshire, England
[2] Astra Zeneca, Stat & Data Management Dept, Loughborough LE11 7RH, Leics, England
关键词
D O I
10.1002/sim.861
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A key tool for assessing the relative cost-effectiveness of two treatments in health economics is the incremental C/E acceptability curve. We present Bayesian computations for this curve in the case where data on both costs and efficacy are available from a clinical trial. Analysis is given under various formulations of prior information. A case study is analysed in which reasonable prior information is shown to strengthen substantially the posterior inference, leading to a more conclusive assessment of cost-effectiveness. Calculations can be performed using readily available Bayesian software. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:733 / 753
页数:21
相关论文
共 50 条